Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia

Published:2021-03-17 Issue:11 Volume:35 Page:3188-3200
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Rivas J. R.^ORCID,Liu Y.^ORCID,Alhakeem S. S.,Eckenrode J. M.,Marti F.,Collard J. P.^ORCID,Zhang Y.,Shaaban K. A.^ORCID,Muthusamy N.,Hildebrandt G. C.^ORCID,Fleischman R. A.,Chen L.,Thorson J. S.,Leggas M.^ORCID,Bondada S.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-021-01217-1.pdf

Reference60 articles.

1. Brusa D, Serra S, Coscia M, Rossi D, D’Arena G, Laurenti L, et al. The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia. Haematologica. 2013;98:953–63.

2. McClanahan F, Riches JC, Miller S, Day WP, Kotsiou E. Neuberg D, et al. Mechanisms of PD-L1/PD-1-mediated CD8 T-cell dysfunction in the context of aging-related immune defects in the Emicro-TCL1 CLL mouse model. Blood. 2015;126:212–21.

3. DiLillo DJ, Weinberg JB, Yoshizaki A, Horikawa M, Bryant JM, Iwata Y, et al. Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function. Leukemia. 2013;27:170–82.

4. Alhakeem SS, McKenna MK, Oben KZ, Noothi SK, Rivas JR, Hildebrandt GC, et al. Chronic Lymphocytic Leukemia-Derived IL-10 Suppresses Antitumor Immunity. J Immunol. 2018;200:4180–9.

5. Alhakeem SS, Sindhava VJ, McKenna MK, Gachuki BW, Byrd JC, Muthusamy N, et al. Role of B cell receptor signaling in IL-10 production by normal and malignant B-1 cells. Ann N Y Acad Sci. 2015;1362:239–49.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The molecular landscape of T cell exhaustion in the tumor microenvironment and reinvigoration strategies;International Reviews of Immunology;2024-09-11

2. Rewiring the T cell-suppressive cytokine landscape of the tumor microenvironment: a new frontier for precision anti-cancer therapy;Frontiers in Immunology;2024-08-30

3. Identifying cell type-specific transcription factor-mediated activity immune modules reveal implications for immunotherapy and molecular classification of pan-cancer;Briefings in Bioinformatics;2024-07-25

4. DNAJC1 facilitates glioblastoma progression by promoting extracellular matrix reorganization and macrophage infiltration;Journal of Cancer Research and Clinical Oncology;2024-06-22

5. Regulation of Treg cells by cytokine signaling and co-stimulatory molecules;Frontiers in Immunology;2024-05-13